Literature DB >> 11083794

Involvement of CD14 and beta2-integrins in activating cells with soluble and particulate lipopolysaccharides and mannuronic acid polymers.

T H Flo1, L Ryan, L Kilaas, G Skjâk-Braek, R R Ingalls, A Sundan, D T Golenbock, T Espevik.   

Abstract

Lipopolysaccharide (LPS) and related bacterial products can be recognized by host inflammatory cells in a particulate, bacterium-bound form, as well as in various soluble, released forms. In the present study we have compared the mechanisms used by LPS, detoxified LPS (DLPS), and mannuronic acid polymers (M-polymers), in solution or covalently linked to particles, in stimulating monocytes to tumor necrosis factor (TNF) production. The addition of recombinant LPS binding protein (LBP) and/or soluble CD14 (sCD14) enhanced the production of TNF from monocytes stimulated with soluble LPS, DLPS, or M-polymer, but did not affect the response to M-polymer or DLPS attached to particles. Treatment of monocytes with antibody to CD14, CD18, or CD11b showed that CD14, but not CR3 (CD11b/CD18), mediated monocyte TNF production in response to the soluble antigens. In contrast, anti-CD14, anti-CD11b and anti-CD18 monoclonal antibodies all inhibited the response to the particulate stimuli. On the other hand, B975, a synthetic analog of Rhodobacter capsulatus lipid A, completely abrogated the monocyte TNF response induced by LPS but did not affect the TNF induction by DLPS or M-polymer, either in soluble or particulate forms. These data demonstrate that the engagement of immune receptors by bacterial products such as LPS, DLPS, and M-polymer is dependent upon the presentation form of their constituent carbohydrates, and that factors such as aggregation state, acylation, carbohydrate chain length, and solid versus liquid phase of bacterial ligands influence the mechanisms used by cells in mediating proinflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083794      PMCID: PMC97779          DOI: 10.1128/IAI.68.12.6770-6776.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide.

Authors:  T H Flo; O Halaas; E Lien; L Ryan; G Teti; D T Golenbock; A Sundan; T Espevik
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Beta 2 integrins are involved in cytokine responses to whole Gram-positive bacteria.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; F Genovese; F Tomasello; T H Flo; T Espevik; G Teti
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

5.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.

Authors:  E Lien; T K Means; H Heine; A Yoshimura; S Kusumoto; K Fukase; M J Fenton; M Oikawa; N Qureshi; B Monks; R W Finberg; R R Ingalls; D T Golenbock
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2.

Authors:  A O Aliprantis; R B Yang; M R Mark; S Suggett; B Devaux; J D Radolf; G R Klimpel; P Godowski; A Zychlinsky
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

8.  Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).

Authors:  B P Thornton; V Vĕtvicka; M Pitman; R C Goldman; G D Ross
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

9.  CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition.

Authors:  R L Delude; R Savedra; H Zhao; R Thieringer; S Yamamoto; M J Fenton; D T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide.

Authors:  R R Ingalls; D T Golenbock
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 2.  Early innate immune responses to bacterial LPS.

Authors:  Charles V Rosadini; Jonathan C Kagan
Journal:  Curr Opin Immunol       Date:  2016-11-12       Impact factor: 7.486

3.  Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation.

Authors:  Hartmut Stoll; Jörn Dengjel; Christiane Nerz; Friedrich Götz
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 4.  Molecular basis of mycobacterial survival in macrophages.

Authors:  Jane Atesoh Awuh; Trude Helen Flo
Journal:  Cell Mol Life Sci       Date:  2016-11-19       Impact factor: 9.261

5.  Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes.

Authors:  Melanie J Scott; Timothy R Billiar
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

Review 6.  Macrophages in tuberculosis: friend or foe.

Authors:  Evelyn Guirado; Larry S Schlesinger; Gilla Kaplan
Journal:  Semin Immunopathol       Date:  2013-07-18       Impact factor: 9.623

7.  The presence of CD14 overcomes evasion of innate immune responses by virulent Francisella tularensis in human dendritic cells in vitro and pulmonary cells in vivo.

Authors:  Jennifer C Chase; Catharine M Bosio
Journal:  Infect Immun       Date:  2009-10-19       Impact factor: 3.441

8.  Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration.

Authors:  Massimiliano De Paola; Alessandro Mariani; Paolo Bigini; Marco Peviani; Giovanni Ferrara; Monica Molteni; Sabrina Gemma; Pietro Veglianese; Valeria Castellaneta; Valentina Boldrin; Carlo Rossetti; Chiara Chiabrando; Gianluigi Forloni; Tiziana Mennini; Roberto Fanelli
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 9.  Monoclonal Antibody to CD14, TLR4, or CD11b: Impact of Epitope and Isotype Specificity on ROS Generation by Human Granulocytes and Monocytes.

Authors:  Dmitry S Kabanov; Sergey V Grachev; Isabella R Prokhorenko
Journal:  Oxid Med Cell Longev       Date:  2020-11-20       Impact factor: 6.543

10.  Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages.

Authors:  Guang Sheng Ling; Jason Bennett; Kevin J Woollard; Marta Szajna; Liliane Fossati-Jimack; Philip R Taylor; Diane Scott; Guido Franzoso; H Terence Cook; Marina Botto
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.